Trial Profile
The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Ovulation disorders
- Focus Pharmacodynamics
- 16 Aug 2012 Results published in the Contraception.
- 19 Oct 2011 Status changed from active, no longer recruiting to completed.
- 19 Oct 2011 Results presented at the 67th Annual Meeting of the American Society for Reproductive Medicine.